Literature DB >> 23036745

Warts and all: human papillomavirus in primary immunodeficiencies.

Jennifer W Leiding1, Steven M Holland.   

Abstract

Infection with human papillomavirus (HPV) is almost universal and eventually asymptomatic, but pathologic infection with HPV is severe, recurrent, and recalcitrant to therapy. It is also an underappreciated manifestation of primary immunodeficiency. Mutations in EVER1, EVER2, GATA2, CXCR4, and dedicator of cytokinesis 8 (DOCK8) are typically associated with extensive HPV infections, whereas several other primary immune defects result in severe HPV much less frequently. We review immunodeficiencies with severe HPV infections and the mechanisms underlying them. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036745      PMCID: PMC3517887          DOI: 10.1016/j.jaci.2012.07.049

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  194 in total

1.  IgG2 deficiency in ataxia-telangiectasia.

Authors:  V A Oxelius; A I Berkel; L A Hanson
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

2.  Immune reactions in epidermodysplasia verruciformis.

Authors:  S Pyrhönen; S Jablonska; S Obałek; E Kuismanen
Journal:  Br J Dermatol       Date:  1980-03       Impact factor: 9.302

3.  B-cell lymphoma in a patient with WHIM syndrome.

Authors:  K M Chae; J O Ertle; M D Tharp
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

4.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

5.  [Netherton syndrome: weakened immunity, generalized verrucosis and carcinogenesis].

Authors:  H Hintner; E Jaschke; P Fritsch
Journal:  Hautarzt       Date:  1980-08       Impact factor: 0.751

6.  [Deaf-mutism, lymphedema of the lower limbs and hematological abnormalities (acute leukemia, cytopenia) with autosomal dominant transmission].

Authors:  J M Emberger; M Navarro; M Dejean; P Izarn
Journal:  J Genet Hum       Date:  1979-10

7.  An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein.

Authors:  C A Crowley; J T Curnutte; R E Rosin; J André-Schwartz; J I Gallin; M Klempner; R Snyderman; F S Southwick; T P Stossel; B M Babior
Journal:  N Engl J Med       Date:  1980-05-22       Impact factor: 91.245

8.  Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Authors:  Cindy Berthelot; Mary C Dickerson; Peter Rady; Qin He; Farhad Niroomand; Stephen K Tyring; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

9.  T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5.

Authors:  W Gliński; S Obałek; S Jabłońska; G Orth
Journal:  Dermatologica       Date:  1981

Review 10.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

View more
  52 in total

1.  Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency.

Authors:  Qurat Ul Ain Kamili; Filiz O Seeborg; Kapil Saxena; Sarah K Nicholas; Pinaki P Banerjee; Laura S Angelo; Emily M Mace; Lisa R Forbes; Caridad Martinez; Teresa S Wright; Jordan S Orange; Imelda Celine Hanson
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

Review 2.  Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome.

Authors:  Hsi-En Ho; Minji Byun; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2018-05-05       Impact factor: 8.317

3.  Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus.

Authors:  Cecilia Frecha; Sébastien A Chevalier; Patrick van Uden; Ivonne Rubio; Maha Siouda; Djamel Saidj; Camille Cohen; Patrick Lomonte; Rosita Accardi; Massimo Tommasino
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

Review 4.  Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders.

Authors:  Katherine M Harris; Blachy J Davila; Catherine M Bollard; Michael D Keller
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

5.  Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

Authors:  Scott B Drutman; Filomeen Haerynck; Franklin L Zhong; David Hum; Nicholas J Hernandez; Serkan Belkaya; Franck Rapaport; Sarah Jill de Jong; David Creytens; Simon J Tavernier; Katrien Bonte; Sofie De Schepper; Jutte van der Werff Ten Bosch; Lazaro Lorenzo-Diaz; Andy Wullaert; Xavier Bossuyt; Gérard Orth; Vincent R Bonagura; Vivien Béziat; Laurent Abel; Emmanuelle Jouanguy; Bruno Reversade; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

Review 6.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 7.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

Review 8.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

Review 9.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

10.  Topical Cidofovir for Recalcitrant Verrucae in Individuals with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation.

Authors:  Sarah E Henrickson; James R Treat
Journal:  Pediatr Dermatol       Date:  2016-10-04       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.